Healthcare Sector
Market Tracker
15m Chart - Support and Resistance levels are based on the large dark pool & equity prints at the plotted levels. Displays strongest levels above and below the spot price.
Represents the strikes that had the highest premium of whale flow (on the ASK side) over the past 5 trading days.
Represents the strikes that had the highest premium of whale flow (on the BID side) over the past 5 trading days.
Represents the largest cumulative premium levels above and below the current spot price. The price in the pink bubble represents the spot price.
Total Open Interest of Calls & Puts across all strikes and expirations over the past 16 trading days.
| Expires | Type | Strike | OI | Change | Percent |
|---|---|---|---|---|---|
| 05/30/2025 | PUT | $58.00 | 10,057 | +9,987 | +14,267.14% |
| 05/23/2025 | PUT | $66.00 | 2,173 | +2,068 | +1,969.52% |
| 05/30/2025 | PUT | $66.00 | 2,108 | +2,026 | +2,470.73% |
| 01/16/2026 | PUT | $52.50 | 3,444 | +390 | +12.77% |
| 12/19/2025 | PUT | $60.00 | 707 | +326 | +85.56% |
| 06/20/2025 | CALL | $90.00 | 3,779 | +168 | +4.65% |
| 05/16/2025 | CALL | $65.00 | 2,987 | -151 | -4.81% |
| 05/16/2025 | PUT | $63.00 | 1,404 | -286 | -16.92% |
| 05/16/2025 | PUT | $75.00 | 1,259 | -290 | -18.72% |
| 05/16/2025 | CALL | $67.00 | 1,613 | -394 | -19.63% |
| 05/16/2025 | PUT | $60.00 | 10,561 | -436 | -3.96% |
| 05/16/2025 | PUT | $62.00 | 2,575 | -467 | -15.35% |
Contracts with largest changes in open interest from the previous trading day to the current/most recent.
| Name | Pct Held | Shares | Total |
|---|---|---|---|
| Harbor Capital Appreciation Fund | 0.18% | 3.11M | 481.53M |
| Washington Mutual Investors Fund | 0.09% | 1.51M | 234.45M |
| Vanguard U.S. Growth Fund | 0.07% | 1.27M | 196.47M |
| Loomis Sayles Growth Fund | 0.07% | 1.18M | 183.13M |
| Fidelity Blue Chip Growth Fund | 0.07% | 1.13M | 175.35M |
| Amana Mutual Funds Trust-Growth Fund | 0.06% | 1M | 155.09M |
| PGIM Jennison Growth Fd | 0.05% | 828.11k | 128.15M |
| Blackrock Equity Dividend Fund | 0.04% | 712k | 110.18M |
| New Perspective Fund Inc | 0.04% | 691.44k | 107M |
| Price (T.Rowe) International Stock Fund | 0.04% | 674k | 104.3M |
Why Viking Therapeutics Stock Bumped 3% Higher Today
05/16 05:20 pm
The Motley Fool
Read moreTrump’s Drug Pricing Order Targets PBMs—Pharma Stocks May Escape the Worst
05/16 01:35 pm
Investing.com
Read moreNovo Nordisk’s CEO Departure Marks Inflection Point for Struggling Pharma Giant
05/16 11:46 am
Investing.com
Read moreWhy Novo Nordisk Stock Just Slipped
05/16 11:07 am
The Motley Fool
Read moreIs It Time to Buy the Dip in Novo Nordisk Stock?
05/15 08:29 am
Investing.com
Read moreSaudi Arabia Active Pharmaceutical Ingredients Market Forecasts & Opportunities Report 2024-2025 & 2030 Featuring Pfizer, Aurobindo Pharma, Novartis, BASF, Viatris, and Novo Nordisk
05/13 04:59 am
GlobeNewswire Inc.
Read moreBig News! U.S. and China Trade Deal Shakes Up Markets
05/12 12:07 pm
The Motley Fool
Read morePost-Earnings Dip: Why This Beaten-Down Stock Is a No-Brainer Buy
05/08 09:05 am
The Motley Fool
Read moreHims & Hers Health Shocks Investors With a Long-Term Forecast, but Is the Stock a Buy?
05/08 05:05 am
The Motley Fool
Read moreNovo Nordisk Predicts Strong Second Half
05/07 09:31 am
The Motley Fool
Read moreNovo Nordisk's Wegovy Sales Surge 85% But Compounded Weight Loss Drugs In US Impacts Annual Outlook
05/07 09:09 am
Benzinga
Read moreHims & Hers Jumps 18.2% on Incredible 111% Revenue Growth
05/07 07:30 am
The Motley Fool
Read moreWhy Viking Therapeutics Stock Surged Nearly 20% Higher in April
05/06 04:33 am
The Motley Fool
Read more3 No-Brainer Stocks to Buy in May
05/05 06:45 am
The Motley Fool
Read moreAmgen's Better Than Expected Q1 Earnings Take Backseat As Eyes Are On MariTide Obesity Data
05/02 03:57 pm
Benzinga
Read moreCVS Caremark To Place Novo Nordisk's Wegovy On Preferred Coverage For GLP-1 Weight Loss Treatment
05/01 02:21 pm
Benzinga
Read moreWhy Eli Lilly Stock Is Sinking Today
05/01 12:49 pm
The Motley Fool
Read moreCVS Health Partners With Wegovy Maker Novo Nordisk, Hikes 2025 Guidance
05/01 11:11 am
Benzinga
Read moreWhy Novo Nordisk Stock Popped Today
05/01 11:11 am
The Motley Fool
Read more1 Beaten-Down Stock to Buy and Hold for 10 Years
05/01 05:47 am
The Motley Fool
Read moreHims & Hers Is Booming — Will Subscribers and Wegovy Deals Justify the Hype?
04/30 01:17 pm
Investing.com
Read moreWhy Novo Nordisk Stock Is Soaring Today
04/29 04:01 pm
The Motley Fool
Read moreWhy Hims & Hers Health and LifeMD Are Skyrocketing Today
04/29 03:19 pm
The Motley Fool
Read moreHims & Hers Stock Surges As It Collaborates With Novo Nordisk To Sell Weight Loss Drug Wegovy On Its Platform
04/29 12:13 pm
Benzinga
Read moreWhy Viking Therapeutics Stock Popped Today
04/28 11:06 am
The Motley Fool
Read moreWhy Novo Nordisk Stock Dropped Today
04/25 10:58 am
The Motley Fool
Read moreViking Therapeutics EPS Miss Overlooked as Long-Term Pipeline Gains Focus
04/25 09:19 am
Investing.com
Read moreIs Eli Lilly Stock Going to $900? 1 Wall Street Analyst Thinks So.
04/23 06:55 am
The Motley Fool
Read moreNovo Nordisk Investors Just Got Terrible News. Should You Sell the Stock?
04/23 05:50 am
The Motley Fool
Read moreIs Eli Lilly Stock a Buy?
04/23 05:07 am
The Motley Fool
Read moreDown 60%, Is This Growth Stock Too Cheap to Ignore?
04/22 05:15 am
The Motley Fool
Read moreDown 61%, Is Novo Nordisk Stock Worth Buying on the Dip?
04/21 09:15 am
The Motley Fool
Read moreDid Eli Lilly Just Say Checkmate to Novo Nordisk?
04/21 04:30 am
The Motley Fool
Read morePrediction: Eli Lilly's Newest GLP-1 Drug Will Be a Game-Changer for the Stock
04/20 06:20 am
The Motley Fool
Read moreEli Lilly's Experimental Weight Loss Pill Succeeded in Its First Pivotal Trial. Is It Time to Buy?
04/19 03:23 am
The Motley Fool
Read moreWhere Will Eli Lilly Be in 5 Years?
04/18 04:51 am
The Motley Fool
Read moreAvoid The Mistake Countless Investors And Advisors Are Making, Oral Weight Loss Drug Is Almost Here
04/17 12:35 pm
Benzinga
Read moreDown 71%, Should You Buy the Dip on Viking Therapeutics Stock?
04/15 10:15 am
The Motley Fool
Read moreWhy Eli Lilly, Novo Nordisk, and Viking Therapeutics Stocks All Popped Today
04/14 11:12 am
The Motley Fool
Read moreBiopharmaceuticals Global Overview Report 2025: Global Market to Reach $698.7 Billion by 2030, Fueled by Specialized Therapies, Such as mAb and Gene Treatments, & a Strong Pipeline
04/10 05:59 am
GlobeNewswire Inc.
Read moreWhy Hims & Hers Health Stock Couldn't Beat the Market Today
04/02 06:18 pm
The Motley Fool
Read moreWhere Will Eli Lilly Be in 1 Year?
04/01 05:37 am
The Motley Fool
Read more1 Growth Stock With Major Catalysts on the Way to Buy and Hold
03/30 03:13 am
The Motley Fool
Read moreNovo Nordisk A/S: Rybelsus® (oral semaglutide 14 mg) demonstrates superior reduction in cardiovascular events in the SOUL trial at ACC 2025
03/29 02:33 pm
GlobeNewswire Inc.
Read moreOzempic® (once-weekly semaglutide 1.0 mg) shown to improve walking distance and quality of life in adults with type 2 diabetes and peripheral artery disease (PAD) at ACC 2025
03/29 10:33 am
GlobeNewswire Inc.
Read moreNovo Nordisk (NVO) Faces Securities Class Action After Weight Loss Therapy Trial Data Disappoints, Analyst Questions Trial’s Design – Hagens Berman
03/22 10:19 am
GlobeNewswire Inc.
Read more1 Biotech Stock Down 52% That Could Soar by 233%, According to Wall Street
03/20 07:19 am
The Motley Fool
Read more